These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21338454)

  • 21. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
    Teschke R
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.
    Lucena MI; Kaplowitz N; Hallal H; Castiella A; García-Bengoechea M; Otazua P; Berenguer M; Fernandez MC; Planas R; Andrade RJ
    J Hepatol; 2011 Oct; 55(4):820-7. PubMed ID: 21338638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.
    Medina-Caliz I; Garcia-Cortes M; Gonzalez-Jimenez A; Cabello MR; Robles-Diaz M; Sanabria-Cabrera J; Sanjuan-Jimenez R; Ortega-Alonso A; García-Muñoz B; Moreno I; Jimenez-Perez M; Fernandez MC; Ginés P; Prieto M; Conde I; Hallal H; Soriano G; Roman E; Castiella A; Blanco-Reina E; Montes MR; Quiros-Cano M; Martin-Reyes F; Lucena MI; Andrade RJ;
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1495-1502. PubMed ID: 29307848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A proposed pathologic sub-classification of drug-induced liver injury.
    Wang T; Zhao X; Shao C; Ye L; Guo J; Peng N; Zhang H; Li J; Kong Y; You H; Jia J
    Hepatol Int; 2019 May; 13(3):339-351. PubMed ID: 30977034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevalence and risk factors of drug induced liver disease: a survey based study in pharmacies].
    Jüngst C; Gräber S; Klahn D; Wedemeyer H; Lammert F
    Z Gastroenterol; 2016 Feb; 54(2):131-8. PubMed ID: 26854832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Update on Drug-induced Liver Injury.
    Devarbhavi H
    J Clin Exp Hepatol; 2012 Sep; 2(3):247-59. PubMed ID: 25755441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK.
    Abbara A; Chitty S; Roe JK; Ghani R; Collin SM; Ritchie A; Kon OM; Dzvova J; Davidson H; Edwards TE; Hateley C; Routledge M; Buckley J; Davidson RN; John L
    BMC Infect Dis; 2017 Mar; 17(1):231. PubMed ID: 28340562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital.
    Ou P; Chen Y; Li B; Zhang M; Liu X; Li F; Li Y; Chen C; Mao Y; Chen J
    Springerplus; 2015; 4():802. PubMed ID: 26702391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review of the incidence of herbal drug-induced liver injury in Korea.
    Oh SJ; Cho JH; Son CG
    J Ethnopharmacol; 2015 Jan; 159():253-6. PubMed ID: 25460587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced liver injury at an Asian center: a prospective study.
    Wai CT; Tan BH; Chan CL; Sutedja DS; Lee YM; Khor C; Lim SG
    Liver Int; 2007 May; 27(4):465-74. PubMed ID: 17403186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury.
    Tsutsui A; Harada K; Tsuneyama K; Senoh T; Nagano T; Takaguchi K; Ando M; Nakamura S; Mizobuchi K; Kudo M
    Dig Dis; 2017; 35(6):506-514. PubMed ID: 29040982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period.
    Baekdal M; Ytting H; Skalshøi Kjær M
    Scand J Gastroenterol; 2017 Apr; 52(4):450-454. PubMed ID: 27973926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury.
    Heidemann L; Law J; Fontana RJ
    Dig Dis Sci; 2017 Mar; 62(3):615-625. PubMed ID: 26597192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Needles in haystacks.
    Reuben A
    Am J Gastroenterol; 2007 Nov; 102(11):2444-6. PubMed ID: 17958757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-Induced liver Injury Associated with Severe Cutaneous Hypersensitivity Reactions: A Complex Entity in Need of a Multidisciplinary Approach.
    Sanabria-Cabrera J; Medina-Cáliz I; Stankevičiūtė S; Rodríguez-Nicolás A; Almarza-Torres M; Lucena MI; Andrade RJ
    Curr Pharm Des; 2019; 25(36):3855-3871. PubMed ID: 31696806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced liver injury.
    Holt M; Ju C
    Handb Exp Pharmacol; 2010; (196):3-27. PubMed ID: 20020257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idiosyncratic drug-induced liver injury: an overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2007 Nov; 6(6):673-84. PubMed ID: 17967156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case definition and phenotype standardization in drug-induced liver injury.
    Aithal GP; Watkins PB; Andrade RJ; Larrey D; Molokhia M; Takikawa H; Hunt CM; Wilke RA; Avigan M; Kaplowitz N; Bjornsson E; Daly AK
    Clin Pharmacol Ther; 2011 Jun; 89(6):806-15. PubMed ID: 21544079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel risk factors and early detection of anti tubercular treatment induced liver injury-Looking beyond American Thoracic Society Guidelines.
    Latief M; Dar WR; Sofi N; Dar IA; Kasana B; Hussain M; Arshad F; Shah BA; Koul PA
    Indian J Tuberc; 2017 Jan; 64(1):26-32. PubMed ID: 28166913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.